Explore evidence

8,825 womenA total of 8825 women of reproductive age living with HIV were surveyed at five comprehensive HIV treatment centres in Benue State, North-Central Nigeria between June and December 2017.

NigeriaVIH/sidaobserved June and December 2017published 2022Journal of biosocial sciencePubMeddocument of 8 observations

18 %Minority variants (<20% frequency) comprised 18% of all mutations in HIV-1 sequences from participants with first-line virological failure in a Nigerian cohort.

NigeriaVIH/sidapublished 2022The Journal of antimicrobial chemotherapyPubMeddocument of 9 observations

8.9 %Non-typeable HIV-1 accounted for 8.9% of cases.

NigeriaVIH/sidaobserved 2009-12published 2016PloS onePubMeddocument of 14 observations

32 %Among participants with endpoint assessments available, 32% (257/809) experienced immunologic failure.

NigeriaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

42.9 %Chronic lung disease (CLD) was more prevalent in people with HIV (42.9%) compared with the HIV-negative group (23%) in Lagos, Nigeria between 2018 and 2019.

Nigeriachronic lung disease · VIH/sidaobserved 2018 and 2019published 2022AIDS (London, England)PubMeddocument of 6 observations

4.43 aORFemale sex workers residing in the North Central geopolitical zone of Nigeria had higher odds of prenatal HIV testing compared to those in the South South zone (adjusted odds ratio = 4.43).

NigeriaVIH/sidapublished 2024International journal of STD & AIDSPubMeddocument of 12 observations

45.6 %Among the 344 women living with HIV, 157 (45.6%) were pre-menopausal, 12 (3.4%) were peri-menopausal, and 175 (51%) were post-menopausal.

NigeriaVIH/sidapublished 2025West African journal of medicinePubMeddocument of 10 observations

41 %In this study, 41% of the 117 youth living with HIV/AIDS in Lagos State demonstrated good sexual and reproductive health knowledge.

NigeriaVIH/sidaobserved 2022published 2025African journal of reproductive healthPubMeddocument of 7 observations

0.47 t_statisticAt 24 weeks, there was no statistically significant change in self-reported depressive symptoms compared to baseline (mean 2.89 vs 2.62; t36=0.47, 95% CI −0.74 to 1.44).

NigeriaVIH/sidapublished 2025JMIR formative researchPubMeddocument of 7 observations

1.93 AORThe adjusted odds ratio for repeat HIV testing among HIV-negative pregnant women at term referred by TBAs in cluster 2 was 1.93 (95% CI [1.3–2.89]).

NigeriaVIH/sidapublished 2024BMC pregnancy and childbirthPubMeddocument of 8 observations

92 %There was a statistically significant reduction in support for viral load testing after the PEPFAR policy change (92% vs. 64%, p = 0.02).

NigeriaVIH/sidaobserved October 2014–September 2015published 2019PloS onePubMeddocument of 11 observations

65.5 %Among young key populations aged 15–24 years in Nigeria, the most cited barrier to pre-exposure prophylaxis (PrEP) uptake was low risk perception (65.5%) among people who inject drugs.

NigeriaVIH/sidaobserved 2020published 2024International journal of STD & AIDSPubMeddocument of 5 observations

37.1 %Among HIV-positive clients in Makurdi, Benue state, Nigeria, Bitter cola/Kola nut was used by 37.1%.

NigeriaVIH/sidapublished 2022West African journal of medicinePubMeddocument of 7 observations

HIV-related knowledge was significantly better in the intervention group at endline.

NigeriaVIH/sidapublished 2020Journal of medical Internet researchPubMeddocument of 5 observations

5.56 odds_ratioAPOL1 high-risk genotype participants were at higher risk of having both an eGFR under 60 ml/min/1.73m² and urine/albumin creatinine ratio over 300 mg/g (adjusted odds ratio 5.56, 95% confidence interval 1.57–19.69).

NigeriaVIH/sidapublished 2021Kidney internationalPubMeddocument of 7 observations

79 %Among Test and Treat patients with a documented viral load, 79% were suppressed (≤400 copies/ml) at six months.

NigeriaVIH/sidapublished 2019PloS onePubMeddocument of 7 observations

2.5 %Among 204,930 participants aged ≥18 months in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018, 5,103 (2.5%) were reactive on test 1 (Determine HIV-1/2).

NigeriaVIH/sidaobserved 2018published 2022PLOS global public healtheurope_pmcdocument of 10 observations

77.3 %Acceptability of the HIV test services was high (77.3%) among clients 20–49 years of age.

NigeriaVIH/sidaobserved 2019published 2024BMC primary carePubMeddocument of 8 observations

32.6 %Needle stick prick accounted for 32.6% of occupational exposures to HIV among healthcare workers.

NigeriaVIH/sidapublished 2020BMC public healthPubMeddocument of 7 observations

12.06 aPRInfants who had mixed feeding had an adjusted Prevalence Ratio of 12.06 for HIV positivity.

NigeriaVIH/sidaobserved 2010 to 2016published 2021Current HIV researchPubMeddocument of 6 observations

17.2 %Sick euthyroid syndrome had a prevalence of 17.2% among HAART-naïve HIV sero-positive patients.

Nigeriasick euthyroid syndrome · VIH/sidapublished 2021West African journal of medicinePubMeddocument of 6 observations

95 %HIV-exposed infants on nevirapine prophylaxis were 95% less likely to be infected with HIV.

NigeriaVIH/sidaobserved 2010 to 2016published 2021Current HIV researchPubMeddocument of 6 observations

25 %The relative risk for mother-to-child transmission of HIV for women with placenta malaria density greater than 5000 was 25%, with a 95% confidence interval of 11.41–54.76%.

Nigeriapaludisme · VIH/sidapublished 2020Malaria journalPubMeddocument of 5 observations

11.4 %HIV seropositive women on HAART co-infected with HSV-2 had a cervical lesion prevalence of 11.4%.

NigeriaCervical Lesions · Herpes Simplex Virus Type-2 · VIH/sidapublished 2022Current HIV researchPubMeddocument of 4 observations

1,900,000 inhabitantsIn 2021, Nigeria had an estimated 1.9 million people living with the human immunodeficiency virus (PLHIV).

NigeriaVIH/sidaobserved 2021published 2024Journal of research in health sciencesPubMeddocument of 5 observations